1. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. Issue 3 (March 2021) Authors: Harrison, Tim W; Chanez, Pascal; Menzella, Francesco; Canonica, Giorgio Walter; Louis, Renaud; Cosio, Borja G; Lugogo, Njira L; Mohan, Arjun; Burden, Annie; McDermott, Lawrence; Garcia Gil, Esther; Zangrilli, James G; Pohl, Wolfgang; Voves, Robert; Deschampheleire, Maud; Louis, Renaud; Martinot, ... Journal: Lancet Issue: Volume 9:Issue 3(2021) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗